Jon P. Stonehouse

Insider Reports History

Location
Birmingham, AL
Signature
/s/ Alane P. Barnes, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jon P. Stonehouse:

Company Role Class Num Shares Value Price $ Report Date Ownership
BIOCRYST PHARMACEUTICALS INC Chief Executive Officer, Director Common Stock 1,405,222 $10,637,530 $7.57 12 Dec 2025 Direct
Metsera, Inc. Director Stock Option (right to buy) 0 $945,531 $19.81 13 Nov 2025 Direct
BIOCRYST PHARMACEUTICALS INC Chief Executive Officer, Director Common Stock 30,000 $207,900 $6.93 12 Dec 2025 By wife as co-trustee of the Caroline Stonehouse Irrevocable Trust
BIOCRYST PHARMACEUTICALS INC Chief Executive Officer, Director Common Stock 30,000 $207,900 $6.93 12 Dec 2025 By wife as co-trustee of the Samuel Stonehouse Irrevocable Trust
BELLICUM PHARMACEUTICALS, INC Director Stock Option (right to buy) 15,000 $21,600 $1.44 15 Jun 2022 Direct
Metsera, Inc. Director Common Stock 0 $0 $52.33 13 Nov 2025 Direct
BIOCRYST PHARMACEUTICALS INC Chief Executive Officer, Director Emp. Stock Option (Right to Buy) 750,250 19 Dec 2024 Direct
BELLICUM PHARMACEUTICALS, INC Director Common Stock 204,086 03 Jan 2023 Direct
BELLICUM PHARMACEUTICALS, INC Director Restricted Stock Units 21,054 04 Jan 2022 Direct
Metsera, Inc. Director Restricted Stock Unit 2,688 13 Nov 2025 Direct

Insider Reports Filed by Jon P. Stonehouse

Symbol Company Period Transactions Value $ Form Type Role Filing Time
BCRX BIOCRYST PHARMACEUTICALS INC 19 Dec 2025 1 -$457,886 4 Chief Executive Officer, Director 23 Dec 2025, 16:13
BCRX BIOCRYST PHARMACEUTICALS INC 18 Dec 2025 3 $0 4 Chief Executive Officer, Director 19 Dec 2025, 16:21
BCRX BIOCRYST PHARMACEUTICALS INC 12 Dec 2025 1 -$207,176 4 Chief Executive Officer, Director 16 Dec 2025, 16:09
MTSR Metsera, Inc. 13 Nov 2025 3 $0 4 Director 13 Nov 2025, 21:00
MTSR Metsera, Inc. 28 Apr 2025 1 +$945,531 4 Director 30 Apr 2025, 21:11
MTSR Metsera, Inc. 28 Apr 2025 0 $0 3 Director 30 Apr 2025, 21:06
BCRX BIOCRYST PHARMACEUTICALS INC 19 Dec 2024 6 -$103,534 4 President & CEO, Director 23 Dec 2024, 16:01
BCRX BIOCRYST PHARMACEUTICALS INC 14 Dec 2024 1 -$207,263 4 President & CEO, Director 17 Dec 2024, 16:16
BCRX BIOCRYST PHARMACEUTICALS INC 13 May 2024 1 +$166,500 4 President & CEO, Director 15 May 2024, 07:08
BCRX BIOCRYST PHARMACEUTICALS INC 03 Jan 2024 3 $0 4 President & CEO, Director 04 Jan 2024, 16:31
BCRX BIOCRYST PHARMACEUTICALS INC 19 Dec 2023 1 -$85,238 4 President & CEO, Director 20 Dec 2023, 16:40
BCRX BIOCRYST PHARMACEUTICALS INC 14 Dec 2023 3 -$87,397 4 President & CEO, Director 18 Dec 2023, 16:43
BCRX BIOCRYST PHARMACEUTICALS INC 13 Jun 2023 1 $0 4 President & CEO, Director 15 Jun 2023, 16:50
BCRX BIOCRYST PHARMACEUTICALS INC 21 Mar 2023 2 +$99,997 4 President & CEO, Director 23 Mar 2023, 16:40
BCRX BIOCRYST PHARMACEUTICALS INC 01 Feb 2023 6 -$493,000 4 President & CEO, Director 02 Feb 2023, 16:20
BLCM BELLICUM PHARMACEUTICALS, INC 03 Jan 2023 1 $0 4 Director 05 Jan 2023, 12:11
BCRX BIOCRYST PHARMACEUTICALS INC 19 Dec 2022 2 $0 4 President & CEO, Director 21 Dec 2022, 15:38
BCRX BIOCRYST PHARMACEUTICALS INC 15 Dec 2022 1 -$153,690 4 President & CEO, Director 19 Dec 2022, 16:09
BCRX BIOCRYST PHARMACEUTICALS INC 01 Dec 2022 6 -$3,429,364 4 President & CEO, Director 02 Dec 2022, 17:33
BLCM BELLICUM PHARMACEUTICALS, INC 01 Sep 2022 1 $0 4/A Director 04 Jan 2023, 19:08
BLCM BELLICUM PHARMACEUTICALS, INC 15 Jun 2022 1 $0 4 Director 16 Jun 2022, 14:48
BCRX BIOCRYST PHARMACEUTICALS INC 11 Jan 2022 3 -$1,897,040 4 President & CEO, Director 13 Jan 2022, 15:45
BLCM BELLICUM PHARMACEUTICALS, INC 04 Jan 2022 2 $0 4/A Director 01 Sep 2022, 16:39
BCRX BIOCRYST PHARMACEUTICALS INC 14 Dec 2021 6 $0 4 President & CEO, Director 16 Dec 2021, 15:53
BLCM BELLICUM PHARMACEUTICALS, INC 15 Jun 2021 1 $0 4 Director 07 Jul 2021, 20:30